back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-14 18:14 Tx date 2025-12-09 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+392,857 vol |
392,857 | |
| Filed 2025-12-14 18:12 Tx date 2025-12-09 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+392,858 vol |
2,631,868 | |
| Filed 2025-12-14 18:10 Tx date 2025-12-09 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-392,858 vol |
0 | |
| Filed 2025-07-14 07:51 Tx date 2025-07-14 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-360,000
-300,000 vol $1.20 each |
0 | |
| Filed 2025-06-25 12:48 Tx date 2025-06-23 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+196,428 vol |
2,239,010 | |
| Filed 2025-06-25 12:47 Tx date 2025-06-23 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+196,428 vol |
2,042,582 | |
| Filed 2025-06-25 12:46 Tx date 2025-06-23 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-196,428 vol |
392,858 | |
| Filed 2025-06-25 12:45 Tx date 2025-06-23 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-196,428 vol |
589,286 | |
| Filed 2025-06-25 12:31 Tx date 2025-06-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+392,857 vol |
785,714 | |
| Filed 2024-12-24 16:36 Tx date 2024-12-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+392,857 vol |
392,857 | |
| Filed 2024-12-11 18:34 Tx date 2024-12-09 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+423,077 vol |
1,846,154 | |
| Filed 2024-12-11 18:33 Tx date 2024-12-09 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-423,077 vol |
0 | |
| Filed 2024-06-28 01:22 Tx date 2024-06-24 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+423,077 vol |
1,423,077 | |
| Filed 2024-06-28 01:21 Tx date 2024-06-24 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-423,077 vol |
423,077 | |
| Filed 2023-12-28 17:20 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
46 - Compensation for services
|
$55,000
+846,154 vol $0.065 each |
846,154 | |
| Filed 2023-12-28 17:10 Tx date 2020-07-13 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-10 15:37 Tx date 2023-03-05 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-490,000
-700,000 vol $0.70 each |
0 | |
| Filed 2021-05-27 17:51 Tx date 2021-05-20 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,245
+18,000 vol $0.0692 each |
363,000 | |
| Filed 2021-05-27 17:30 Tx date 2021-05-27 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$19,718
+237,000 vol $0.0832 each |
700,000 | |
| Filed 2021-05-27 17:29 Tx date 2021-05-26 |
$LABS
MediPharm Labs Corp. |
Taves, Christopher David
4 - Director of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$4,000
+50,000 vol $0.08 each |
463,000 |